"US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "Dul\u00ED\u010Dek, P." . . . . "V" . "464970" . "Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia" . "RIV/00023736:_____/06:00006851!RIV09-MZ0-00023736" . . "Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia" . "myeloproliferative disorders; treatment guidelines; risk factors; thrombosis; thrombophilia; leukemogenicity of hydroxyurea; interferon; anagrelide"@en . "Seminars in Thrombosis and Hemostasis" . . "Schwarz, Ji\u0159\u00ED" . . "2"^^ . "Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia"@en . . . . . "0094-6176" . "K\u0159en, L." . "L\u00E9\u010Dba zalo\u017Een\u00E1 na stanoven\u00ED rizika u myeloproliferativn\u00EDch onemocn\u011Bn\u00ED mus\u00ED b\u00FDt zalo\u017Eena na zv\u00E1\u017Een\u00ED rizika tromb\u00F3zy a leukemogenicity hydroxyurey. Uvedena terapeutick\u00E1 doporu\u010Den\u00ED \u010Cesk\u00E9 hematologick\u00E9 spole\u010Dnosti."@cs . . "Risk adapted treatment strategies in Ph- myeloproliferative disorders with thrombocythemia has to conform with the risks of thrombosis and the possible leukemogenicity of hydroxyurea. Treatment guidelines of the Czech Hematological Society are explained." . "32" . . "Pytl\u00EDk, R." . "Brychtov\u00E1, Y." . "Analysis of risk factors : the rationale of the guidelines of the Czech hematological society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia"@en . "Risk adapted treatment strategies in Ph- myeloproliferative disorders with thrombocythemia has to conform with the risks of thrombosis and the possible leukemogenicity of hydroxyurea. Treatment guidelines of the Czech Hematological Society are explained."@en . "Campr, V\u00EDt" . . . "15"^^ . . . "3" . "Anal\u00FDza rizikov\u00FDch faktor\u016F u l\u00E9\u010Dby myeloproliferativn\u00EDch onemocn\u011Bn\u00ED : terapeutick\u00E1 doporu\u010Den\u00ED \u010Cesk\u00E9 hematologick\u00E9 spole\u010Dnosti"@cs . "Penka, M." . . . "Anal\u00FDza rizikov\u00FDch faktor\u016F u l\u00E9\u010Dby myeloproliferativn\u00EDch onemocn\u011Bn\u00ED : terapeutick\u00E1 doporu\u010Den\u00ED \u010Cesk\u00E9 hematologick\u00E9 spole\u010Dnosti"@cs . . "[E7437CD2B7FC]" . . "Doubek, M." . "8"^^ . "000237356400006" . "RIV/00023736:_____/06:00006851" .